{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T21:24:33Z","timestamp":1790803473821,"version":"4.1.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T00:00:00Z","timestamp":1698710400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T00:00:00Z","timestamp":1698710400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Menarini"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Poor sleep quality is frequent among COPD patients and it has been related to worse outcomes. The objective of this study was to compare the COPD and Asthma Sleep Impact Scale (CASIS) and the generic Pittsburgh Sleep Quality Index (PSQI) questionnaires as reliable tools for evaluating sleep quality and its relationship with COPD characteristics and survival. Stable COPD patients were prospectively evaluated. Anthropometric, sociodemographic, comorbidity, lung function and treatment data were collected. All patients completed CASIS and PSQI, mMRC dyspnea severity scale, COPD Assessment Test (CAT), sleep apnoea STOP-Bang and Hospital Anxiety and Depression Scale (HADS) questionnaires. Body mass index, airflow Obstruction, Dyspnea and Exacerbations (BODEx) index was calculated. Life status was determined after a mean follow-up of 3.7 (SD 1) years. We included 200 patients, 69.5% male, mean age 65.8 (9) years. Poor sleep was detected in 100 (50%) and 84 patients (42%) according to PSQI and CASIS questionnaires, respectively, with an agreement of 63%. Poor sleep was related to female gender, more severe dyspnea and worse BODEx, HADS and CAT scores according to both questionnaires. PSQI was associated to chronic pain or inferior urinary tract symptoms and CASIS to exacerbations, shorter walked distance in the 6-min walking test and treatment with oral corticosteroids or chronic oxygen. Thirty nine (19.5%) patients died during follow-up. Mortality was not associated to PSQI nor CASIS results. Unlike PSQI, CASIS is more related to COPD severity and its results are not influenced by comorbidities with known impact on sleep quality. In our sample, poor sleep quality was not associated with increased mortality.<\/jats:p>","DOI":"10.1038\/s41598-023-45717-9","type":"journal-article","created":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T07:02:15Z","timestamp":1698735735000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Poor sleep quality, COPD severity and survival according to CASIS and Pittsburgh questionnaires"],"prefix":"10.1038","volume":"13","author":[{"given":"J\u00falia","family":"Sampol","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Miravitlles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda","family":"S\u00e1ez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mercedes","family":"Pallero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel","family":"Sampol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaume","family":"Ferrer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,10,31]]},"reference":[{"key":"45717_CR1","doi-asserted-by":"publisher","first-page":"1900610","DOI":"10.1183\/13993003.00610-2019","volume":"54","author":"I Blanco","year":"2019","unstructured":"Blanco, I., Diego, I., Bueno, P., Casas-Maldonado, F. & Miravitlles, M. Geographic distribution of COPD prevalence in the World displayed by Geographic Information System maps. Eur Respir J. 54, 1900610 (2019).","journal-title":"Eur Respir J."},{"key":"45717_CR2","doi-asserted-by":"publisher","first-page":"2300239","DOI":"10.1183\/13993003.00239-2023","volume":"61","author":"A Agust\u00ed","year":"2023","unstructured":"Agust\u00ed, A. et al. Global Initiative for Chronic Obstructive Lung Disease 2023 Report: GOLD Executive Summary. Eur Respir J. 61, 2300239 (2023).","journal-title":"Eur Respir J."},{"key":"45717_CR3","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1378\/chest.08-0934","volume":"135","author":"JM Parish","year":"2009","unstructured":"Parish, J. M. Sleep-Related Problems in Common Medical Conditions. Chest. 135, 563\u2013572 (2009).","journal-title":"Chest."},{"key":"45717_CR4","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/j.sleep.2011.12.007","volume":"13","author":"TA Omachi","year":"2012","unstructured":"Omachi, T. A. et al. Disturbed sleep among COPD patients is longitudinally associated with mortality and adverse COPD outcomes. Sleep Med. 13, 476\u2013483 (2012).","journal-title":"Sleep Med."},{"key":"45717_CR5","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1183\/09059180.00004311","volume":"20","author":"A Agusti","year":"2011","unstructured":"Agusti, A. et al. Night-time symptoms: a forgotten dimension of COPD. Eur Respir Rev. 20, 183\u2013194 (2011).","journal-title":"Eur Respir Rev."},{"issue":"Suppl 5","key":"45717_CR6","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/S0300-2896(09)72948-5","volume":"45","author":"JL L\u00f3pez-Campos","year":"2009","unstructured":"L\u00f3pez-Campos, J. L. Importance of fatigue, sleep quality and mood in patients with chronic obstructive pulmonary disease and the need for measurement instruments. Arch Bronconeumol. 45(Suppl 5), 2\u20136 (2009).","journal-title":"Arch Bronconeumol."},{"key":"45717_CR7","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/0165-1781(89)90047-4","volume":"28","author":"DJ Buysse","year":"1989","unstructured":"Buysse, D. J., Reynolds, C. F. 3rd., Monk, T. H., Berman, S. R. & Kupfer, D. J. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res. 28, 193\u2013213 (1989).","journal-title":"Psychiatry Res."},{"key":"45717_CR8","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.smrv.2015.01.009","volume":"25","author":"T Mollayeva","year":"2016","unstructured":"Mollayeva, T. et al. The Pittsburgh sleep quality index as a screening tool for sleep dysfunction in clinical and non-clinical samples: A systematic review and meta-analysis. Sleep Med Rev. 25, 52\u201373 (2016).","journal-title":"Sleep Med Rev."},{"key":"45717_CR9","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1016\/j.sleep.2012.03.017","volume":"13","author":"AGM Cavalcante","year":"2012","unstructured":"Cavalcante, A. G. M. et al. Restless legs syndrome, sleep impairment, and fatigue in chronic obstructive pulmonary disease. Sleep Med. 13, 842\u2013847 (2012).","journal-title":"Sleep Med."},{"key":"45717_CR10","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/s00408-009-9147-5","volume":"187","author":"DM Nunes","year":"2009","unstructured":"Nunes, D. M. et al. Impaired Sleep Reduces Quality of Life in Chronic Obstructive Pulmonary Disease. Lung. 187, 159\u2013163 (2009).","journal-title":"Lung."},{"key":"45717_CR11","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1016\/j.rmed.2010.02.020","volume":"104","author":"MJ Hynninen","year":"2010","unstructured":"Hynninen, M. J., Bjerke, N., Pallesen, S., Bakke, P. S. & Nordhus, I. H. A randomized controlled trial of cognitive behavioral therapy for anxiety and depression in COPD. Respir Med. 104, 986\u2013994 (2010).","journal-title":"Respir Med."},{"key":"45717_CR12","doi-asserted-by":"publisher","first-page":"437","DOI":"10.3109\/15412555.2011.623737","volume":"8","author":"G Aras","year":"2011","unstructured":"Aras, G. et al. Are We Aware of Restless Legs Syndrome in COPD Patients Who Are in an Exacerbation Period? Frequency and Probable Factors Related to Underlying Mechanism. COPD. 8, 437\u2013443 (2011).","journal-title":"COPD."},{"key":"45717_CR13","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/1477-7525-7-98","volume":"7","author":"RF Pokrzywinski","year":"2009","unstructured":"Pokrzywinski, R. F., Meads, D. M., McKenna, S. P., Glendenning, G. A. & Revicki, D. A. Development and psychometric assessment of the COPD and Asthma Sleep Impact Scale (CASIS). Health Qual Life Outcomes. 7, 98 (2009).","journal-title":"Health Qual Life Outcomes."},{"key":"45717_CR14","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1159\/000341175","volume":"86","author":"M Miravitlles","year":"2013","unstructured":"Miravitlles, M. et al. Usefulness of the LCOPD, CAFS and CASIS Scales in Understanding the Impact of COPD on Patients. Respiration. 86, 190\u2013200 (2013).","journal-title":"Respiration."},{"key":"45717_CR15","doi-asserted-by":"crossref","unstructured":"Ierodiakonou D, Bouloukaki I, Kampouraki M, Papadokostakis P, Poulorinakis I, Lampraki I, et al. Subjective sleep quality is associated with disease status in COPD patients. The cross-sectional Greek UNLOCK study. Sleep Breath. 2020; 24:1599\u2013605.","DOI":"10.1007\/s11325-020-02039-8"},{"key":"45717_CR16","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","volume":"40","author":"ME Charlson","year":"1987","unstructured":"Charlson, M. E., Pompei, P., Ales, K. L. & MacKenzie, C. R. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 40, 373\u2013383 (1987).","journal-title":"J Chronic Dis."},{"key":"45717_CR17","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1136\/thx.54.7.581","volume":"54","author":"JC Bestall","year":"1999","unstructured":"Bestall, J. C. et al. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax. 54, 581\u2013586 (1999).","journal-title":"Thorax."},{"key":"45717_CR18","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1183\/09031936.00102509","volume":"34","author":"PW Jones","year":"2009","unstructured":"Jones, P. W. et al. Development and first validation of the COPD Assessment Test. Eur Respir J. 34, 648\u2013654 (2009).","journal-title":"Eur Respir J."},{"key":"45717_CR19","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1097\/ALN.0b013e31816d83e4","volume":"108","author":"F Chung","year":"2008","unstructured":"Chung, F. et al. STOP questionnaire: a tool to screen patients for obstructive sleep apnea. Anesthesiology. 108, 812\u2013821 (2008).","journal-title":"Anesthesiology."},{"key":"45717_CR20","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1111\/j.1600-0447.1983.tb09716.x","volume":"67","author":"AS Zigmond","year":"1983","unstructured":"Zigmond, A. S. & Snaith, R. P. The hospital anxiety and depression scale. Acta Psychiatr Scand. 67, 361\u2013370 (1983).","journal-title":"Acta Psychiatr Scand."},{"key":"45717_CR21","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1016\/j.rmed.2008.12.005","volume":"103","author":"JJ Soler-Catalu\u00f1a","year":"2009","unstructured":"Soler-Catalu\u00f1a, J. J., Mart\u00ednez-Garc\u00eda, M. A., S\u00e1nchez S\u00e1nchez, L., Perpi\u00f1\u00e1Tordera, M. & Rom\u00e1n, S. P. Severe exacerbations and BODE index: two independent risk factors for death in male COPD patients. Respir Med. 103, 692\u2013699 (2009).","journal-title":"Respir Med."},{"key":"45717_CR22","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1177\/1359105316684937","volume":"22","author":"A Eslaminejad","year":"2017","unstructured":"Eslaminejad, A., Safa, M., Boroujerdi, F. G., Hajizadeh, F. & Foroush, M. P. Relationship between sleep quality and mental health according to demographics of 850 patients with chronic obstructive pulmonary disease. J Health Psychol. 22, 1603\u20131613 (2017).","journal-title":"J Health Psychol."},{"key":"45717_CR23","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1111\/crj.13085","volume":"13","author":"SH Lee","year":"2019","unstructured":"Lee, S. H. et al. Sleep disturbance in patients with mild-moderate chronic obstructive pulmonary disease. Clin Respir J. 13, 751\u2013757 (2019).","journal-title":"Clin Respir J."},{"key":"45717_CR24","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.rmed.2017.06.017","volume":"129","author":"M Miravitlles","year":"2017","unstructured":"Miravitlles, M. et al. The variability of respiratory symptoms and associated factors in COPD. Respir Med. 129, 165\u2013172 (2017).","journal-title":"Respir Med."},{"key":"45717_CR25","doi-asserted-by":"crossref","unstructured":"Zeidler MR, Martin JL, Kleerup EC, Schneider H, Mitchell MN, Hansel NN, et al. Sleep disruption as a predictor of quality of life among patients in the subpopulations and intermediate outcome measures in COPD study (SPIROMICS). Sleep. 2018;41:zsy044.","DOI":"10.1093\/sleep\/zsy044"},{"key":"45717_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2147\/COPD.S15666","volume":"6","author":"SM Scharf","year":"2010","unstructured":"Scharf, S. M. et al. Sleep quality predicts quality of life in chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 6, 1\u201312 (2010).","journal-title":"Int J Chron Obstruct Pulmon Dis."},{"key":"45717_CR27","first-page":"389","volume":"10","author":"J Geiger-Brown","year":"2015","unstructured":"Geiger-Brown, J. et al. Self-reported sleep quality and acute exacerbations of chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 10, 389\u2013397 (2015).","journal-title":"Int J Chron Obstruct Pulmon Dis."},{"issue":"1","key":"45717_CR28","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1038\/s41598-021-04610-z","volume":"12","author":"N Koulouris","year":"2022","unstructured":"Koulouris, N. et al. Self-perceived quality of sleep among COPD patients in Greece: the SLEPICO study. Sci Rep. 12(1), 540 (2022).","journal-title":"Sci Rep."},{"key":"45717_CR29","doi-asserted-by":"publisher","first-page":"2082","DOI":"10.1016\/S0140-6736(21)00393-7","volume":"397","author":"SP Cohen","year":"2021","unstructured":"Cohen, S. P., Vase, L. & Hooten, W. M. Chronic pain: an update on burden, best practices, and new advances. Lancet. 397, 2082\u20132097 (2021).","journal-title":"Lancet."},{"key":"45717_CR30","doi-asserted-by":"crossref","unstructured":"Taylor BC, Wilt TJ, Fink HA, Lambert LC, Marshall LM, Hoffman AR, et al. Osteoporotic Fractures in Men (MrOS) Study Research Group. Prevalence, severity, and health correlates of lower urinary tract symptoms among older men: the MrOS study. Urology. 2006;68:804\u20139.","DOI":"10.1016\/j.urology.2006.04.019"},{"key":"45717_CR31","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1007\/s00192-012-1743-x","volume":"23","author":"VA Minassian","year":"2012","unstructured":"Minassian, V. A., Yan, X., Lichtenfeld, M. J., Sun, H. & Stewart, W. F. The iceberg of health care utilization in women with urinary incontinence. Int Urogynecol J. 23, 1087\u20131093 (2012).","journal-title":"Int Urogynecol J."},{"key":"45717_CR32","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1111\/j.1440-1843.2012.02190.x","volume":"17","author":"K Ito","year":"2012","unstructured":"Ito, K. et al. Depression, but not sleep disorder, is an independent factor affecting exacerbations and hospitalization in patients with chronic obstructive pulmonary disease. Respirology. 17, 940\u2013949 (2012).","journal-title":"Respirology."},{"key":"45717_CR33","doi-asserted-by":"publisher","first-page":"199","DOI":"10.2147\/COPD.S184127","volume":"14","author":"S Lehmann","year":"2019","unstructured":"Lehmann, S. et al. A randomized trial to determine the impact of indacaterol\/glycopyrronium on nighttime oxygenation and symptoms in patients with moderate-to-severe COPD: the DuoSleep study. Int J Chron Obstruct Pulmon Dis. 14, 199\u2013210 (2019).","journal-title":"Int J Chron Obstruct Pulmon Dis."},{"key":"45717_CR34","doi-asserted-by":"crossref","unstructured":"McCarter SJ, Hagen PT, St. Louis EK, Rieck TM, Haider CR, Holmes DR, Morgenthaler TI. Physiological markers of sleep quality: A scoping review. Sleep Med Rev. 2022;64:101657.","DOI":"10.1016\/j.smrv.2022.101657"},{"key":"45717_CR35","doi-asserted-by":"crossref","unstructured":"Li Y, Zhang X, Winkelman JW, Redline S, Hu FB, Stampfer M, et al. Association between insomnia symptoms and mortality: a prospective study of U.S. men. Circulation. 2014;129:737\u201346.","DOI":"10.1161\/CIRCULATIONAHA.113.004500"},{"key":"45717_CR36","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.amjmed.2014.10.015","volume":"128","author":"S Parthasarathy","year":"2015","unstructured":"Parthasarathy, S. et al. Persistent insomnia is associated with mortality risk. Am J Med. 128, 268\u2013275 (2015).","journal-title":"Am J Med."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-45717-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-45717-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-45717-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T07:06:58Z","timestamp":1698736018000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-45717-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,31]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["45717"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-45717-9","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,31]]},"assertion":[{"value":"15 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"JF has received fees from AstraZeneca, Novartis, Boehringer Ingelheim, Chiesi and GlaxoSmihtKline, and a research grant from Air Liquide Foundation. MM has received speaker fees from AstraZeneca, Boehringer Ingelheim, Chiesi, Cipla, GlaxoSmithKline, Menarini, Kamada, Takeda, Zambon, CSL Behring, Specialty Therapeutics, Janssen, Grifols and Novartis, consulting fees from AstraZeneca, Atriva Therapeutics, Boehringer Ingelheim, Chiesi, GlaxoSmithKline, CSL Behring, Inhibrx, Ferrer, Menarini, Mereo Biopharma, Spin Therapeutics, Specialty Therapeutics, ONO Pharma, Palobiofarma SL, Takeda, Novartis, Novo Nordisk, Sanofi, Zambon and Grifols and research grants from Grifols. JS, MS, MP and GS declare to have no conflict of interest. The funders had no role in the design of the study, in the collection, analyses, or interpretation of data, in the writing of the manuscript, or in the decision to publish the results.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"18656"}}